However, the 2017 KDIGO guideline suggests aggressive control of serum parathyroid hormone, calcium, phosphorus, and vitamin D level for the CKD-MBD patient (Isakova et al., 2017). The gene discussed is PTH; the disease is Marchiafava-Bignami disease.